<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02479503</url>
  </required_header>
  <id_info>
    <org_study_id>ATC</org_study_id>
    <nct_id>NCT02479503</nct_id>
  </id_info>
  <brief_title>Antibiotic Prophylaxis in Adult Heart Transplantation: a French National Survey</brief_title>
  <acronym>ATC</acronym>
  <official_title>Antibiotic Prophylaxis in Adult Heart Transplantation: a French National Survey</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study focuses on the antibiotic prophylaxis use in adult heart transplantation in France.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In adult heart transplantation, clinical situations differ between patients (elective,
      emergency, redux surgery, ventricular assisting device or extracorporeal live saving). At
      investigator's knowledge, there is not recommendations in France about antibiotic prophylaxis
      in adult heart transplantation. So, investigators aimed to study the antibiotic prophylaxis
      use in adult heart transplantation in France.

      Investigators conduct a French national survey about antibiotic prophylaxis used in adult
      heart transplantation center. Clinical situations such as elective, emergency, redux surgery,
      ventricular assisting device or extracorporeal live saving are investigated.

      Study was performed after Institutional approval was obtained from the local Ethics Committee
      (Comite de Protection des Personnes Nord Ouest III). An electronic survey was sent to all
      French adult heart transplantation centers (22) on march 1st, 2015. Reminders were planned on
      week 2 and 4 after initial sending. On june 2015, nonresponding centers were contacted by
      phone. Data were collected by a single investigator.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2015</start_date>
  <completion_date type="Actual">July 2015</completion_date>
  <primary_completion_date type="Actual">June 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Class of antibiotic used as prophylaxis in adult heart transplantation</measure>
    <time_frame>one year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Class of antibiotic used as prophylaxis in adult heart transplantation in regard to clinical situation</measure>
    <time_frame>one year</time_frame>
    <description>elective, emergency, redux surgery, ventricular assisting device or extracorporeal live saving</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fungal prophylaxis in adult heart transplantation</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Other prophylactic measures (isolation, specific room, family visits) used in adult heart transplantation</measure>
    <time_frame>one year</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">21</enrollment>
  <condition>Antibiotic Prophylaxis</condition>
  <condition>Adult Heart Transplantation</condition>
  <arm_group>
    <arm_group_label>French Adult Heart Transplantation Center</arm_group_label>
    <description>All center performing adult heart transplantation in France in 2015.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Antibiotic prophylaxis in adult heart transplantation</intervention_name>
    <arm_group_label>French Adult Heart Transplantation Center</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All French centers perfoming adult heart transplantation in 2015.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All French centers performing adult heart transplantation in 2015

        Exclusion Criteria:

          -  not responding center

          -  no adult heart transplantation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Caen University Hospital</name>
      <address>
        <city>Caen</city>
        <state>Normandy</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Zuckermann A, Barten MJ. Surgical wound complications after heart transplantation. Transpl Int. 2011 Jul;24(7):627-36. doi: 10.1111/j.1432-2277.2011.01247.x. Epub 2011 Mar 21. Review.</citation>
    <PMID>21418335</PMID>
  </reference>
  <reference>
    <citation>Montoya JG, Giraldo LF, Efron B, Stinson EB, Gamberg P, Hunt S, Giannetti N, Miller J, Remington JS. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis. 2001 Sep 1;33(5):629-40. Epub 2001 Aug 6. Review.</citation>
    <PMID>11486285</PMID>
  </reference>
  <reference>
    <citation>Ramos A, Asensio A, Muñez E, Torre-Cisneros J, Blanes M, Carratalá J, Segovia J, Munoz P, Cisneros JM, Bou G, Aguado JM, Cervera C, Gurgui MM. Incisional surgical infection in heart transplantation. Transpl Infect Dis. 2008 Jul;10(4):298-302. doi: 10.1111/j.1399-3062.2008.00316.x. Epub 2008 May 15.</citation>
    <PMID>18482203</PMID>
  </reference>
  <verification_date>June 2015</verification_date>
  <study_first_submitted>June 12, 2015</study_first_submitted>
  <study_first_submitted_qc>June 19, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2015</study_first_posted>
  <last_update_submitted>April 13, 2020</last_update_submitted>
  <last_update_submitted_qc>April 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>antibiotic prophylaxis heart transplantation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

